| pubmed-article:17206695 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17206695 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17206695 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17206695 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:17206695 | lifeskim:mentions | umls-concept:C0021390 | lld:lifeskim |
| pubmed-article:17206695 | lifeskim:mentions | umls-concept:C0127615 | lld:lifeskim |
| pubmed-article:17206695 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
| pubmed-article:17206695 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:17206695 | pubmed:dateCreated | 2007-5-25 | lld:pubmed |
| pubmed-article:17206695 | pubmed:abstractText | Patients with inflammatory bowel disease (IBD) affecting the colon are at increased risk of developing colorectal cancer (CRC). Published data are conflicting about whether 5-aminosalicylic acid (5-ASA) has chemopreventive properties against IBD-related carcinogenesis. The objective of this observational study was to determine if an association between 5-ASA therapy and CRC risk exists in IBD patients. | lld:pubmed |
| pubmed-article:17206695 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17206695 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17206695 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17206695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17206695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17206695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17206695 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17206695 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:17206695 | pubmed:issn | 1078-0998 | lld:pubmed |
| pubmed-article:17206695 | pubmed:author | pubmed-author:RubinDavid... | lld:pubmed |
| pubmed-article:17206695 | pubmed:author | pubmed-author:TerdimanJonat... | lld:pubmed |
| pubmed-article:17206695 | pubmed:author | pubmed-author:UllmanThomas... | lld:pubmed |
| pubmed-article:17206695 | pubmed:author | pubmed-author:SteinbuchMich... | lld:pubmed |
| pubmed-article:17206695 | pubmed:author | pubmed-author:BlumentalsWil... | lld:pubmed |
| pubmed-article:17206695 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17206695 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:17206695 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17206695 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17206695 | pubmed:pagination | 367-71 | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:meshHeading | pubmed-meshheading:17206695... | lld:pubmed |
| pubmed-article:17206695 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17206695 | pubmed:articleTitle | 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. | lld:pubmed |
| pubmed-article:17206695 | pubmed:affiliation | University of California, San Francisco, San Francisco, California 94143-1623, USA. Jonathan.Terdiman@ucsf.edu | lld:pubmed |
| pubmed-article:17206695 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17206695 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17206695 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17206695 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17206695 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17206695 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17206695 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17206695 | lld:pubmed |
